glutathione and parkinson's disease Potential use of as a treatment for The glutathione system in Parkinson's

BPC 157 has strong angiogenic potential, it acts protectively on endothelium, prevents and reverses thrombus formation after abdominal aorta anastomosis, affects many central disturbances (i.e., dopamine and 5-HT system), the NO-system (either Larginine and L-NAME effects), endothelin, acts as a free radical scavenger (counteracting CCl4-, paracetamol-, diclofenac-injuries) and exhibits neuroprotective properties

Christina Rahm, encourages the natural production of glutathione

The NADPH Connection The most direct link involves NADPH (the phosphorylated version of NAD+)

Supports anti-aging and UV protection

The global market for Copper Peptide GHK-Cu was valued at around USD 170 million in a recent year and is projected to explode to nearly USD 500 million by the end of the decade